Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$54.8M
10M shares
52-week range
$4.34 – $7.50
31% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
XASE
CS
Alpha Pro Tech Ltd is in the business of protecting people, products, and environments. It is developing, manufacturing, and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical, and dental markets. It also manufactures a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply, consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment, and synthetic roof underlayment accessories.
www.alphaprotech.comNo one on the platform currently holds APT.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 544,072 | $2.4M |
No one on the platform has traded APT yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$APT Price has been doing quite nice here. My average is at $5.077, sold about a third on the trend up to $5.50 the last few days, and I sold some covered calls at the $6 strike. Hoping to see us range between $5.30 and $5.50 for a while. Giving earnings was so strong last quarter, I'm thinking the Floor has moved from $4.00~ to around $4.15~.
View on StockTwits ↗$APT Revised with corrected figures: Is APT 28.9% undervalued? PT $7.38 Q3 25: $976,000. $0.09 Q4 25: $698,000. $0.07 Q1 26: $720,000. $0.07 Q2 26: $1,800,000. $0.18 TTM 26: $4,194,000 2026 Q2 Sharecount: 10,120,851 TTM EPS : $0.4143 10,120,851 Also 10,347,645 diluted as of 6/30/26. Total outstanding shares 10.120M Tangible book value: $6.415 Diluted Tangible Book: $6.275 TTM P/E = 12.79 Fwd P/E= 12.93 Historical average P/E = 18.3x Historical average P/B = 1.12x Is APT 28.9% undervalued? PT $7.38
View on StockTwits ↗$APT PY 2025 for comparison: Q1 25: $613,000 $0.06 Q2 25: $1,244,000 $0.12 TTM Q3 25: $976,000. $0.09 Q4 25: $698,000. $0.07 Q1 26: $720,000. $0.07 Q2 26: $1,800,000. $0.18 TTM 26: $4,194,000 2026 Q2 Sharecount: 10,120,851 TTM EPS : $0.4143 10,120,851 Also 10,347,645 diluted as of 6/30/26. Total outstanding shares 10.120M Tangible book value: $6.415 Diluted Tangible Book: $6.275 TTM P/E = 12.79 Fwd P/E= 12.93 Historical average P/E = 18.9x Historical average P/B = 1.6x Is APT 40.7% undervalued? PT $8.94
View on StockTwits ↗$APT Huge Beat. $0.18/share. Sales up. Cash on hand over $18M. Anyone want to start a shareholder lawsuit for them stopping repurchases with so much cash and a share price 50% under what it should be?
View on StockTwits ↗$APT The company’s management is garbage and the board has violated their fiduciary duty to act on behalf of investors, BUT in no world is this stock worth less than $5 at this point. Tangible Book value will be above mid-$6 by year-end and the new Ebola strain spread seems to be unstoppable at this point. It’s getting a bit worrying to be honest.
View on StockTwits ↗$APT Mainstream media may have fallen silent, but the reporting is getting worse on the Ebola crisis. Take a rewatch of “The Hot Zone” S1 based on real past events, if you don’t know much about Ebola. Ebola is a very serious illness, resulting in upwards of 30% casualties, demanding much more serious focus than the explosive diarrhea outbreak getting all of the focus currently. 🧨💩 I agree that all of these recent outbreaks are likely the result of cost-cutting for preventative measures. PPE sales may rise and fall in cycles, but the need is most high when preventative measures have been reduced. I think this stock should be a LT buy/hold, but agree it may not be the top-performing stock in your portfolio. Just a good and necessary holding in times such as these. https://www.inquirer.com/news/nation-world/ebola-congo-deaths-health-workers-20260720.html
View on StockTwits ↗$APT The volume is looking odd again today. Huge 20,000-46,250 share block trades 3 times.
View on StockTwits ↗$ETH.X $BTC.X $APT $LINK.X $QQQ What's interesting is that some people seem to have the impression that the adoption of blockchain would be bad for them. Nothing could be further from the truth. The myriad of ways blockchain adoption would affect the US consumer are all good for the US and for consumers. More capital would flow to the US. Consumers would have greater control over their finances (less credit card fees for example). The entire system would be more efficient and save consumers billions or trillions over time. It's also the only way it's going to be possible to monetize AI, and take advantage of the lead the US has in that technology. IDK how the technology got so misunderstood (it always has been really). But if you are a US consumer, you should DEFINATELY be in favor of passing he Claarity Act for all positive ways it's going to benefit the US consumer and the US economy.
View on StockTwits ↗$APT Average price for me is $5.07. I've been churning shares in this low $5.00 range the last several days to capture some of the range here. I'm still not convinced this is the bottom though. I'm like 50/50 if it goes up or down from here.
View on StockTwits ↗$APT Looks like some stabilization around the $4.90 - $5.10 level the last 2 days. Is this a pause before the next leg down, or the bottom?
View on StockTwits ↗$APT Added, we've filled the gap from the ebola news breaking. I don't think they're likely to benefit from the outbreak, it's just a cheap stock with relatively low risk of significant downside from here.
View on StockTwits ↗@MrUnBearOrBull imo the Ebola crisis in Africa won't convert to noticeable sales for $APT. I could be wrong of course, we'll see in Q4.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $102M | +0.0% | $1.79 | $1.79–$1.79 | 3.0× | 1 |
| 2027 | $100M | -2.0% | $1.38 | $1.38–$1.38 | 3.8× | 1 |
| 2028 | $89M | -10.3% | $1.16 | $1.16–$1.16 | 4.6× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $0.33 | $0.18 | -45.5% |
| 2026-05-07 | $0.33 | $0.07 | -78.8% |
| 2026-03-11 | $0.29 | $0.07 | -75.9% |
| 2025-11-05 | $0.32 | $0.09 | -71.9% |
| 2025-08-07 | $0.28 | $0.12 | -57.1% |
| 2025-05-08 | $0.27 | $0.06 | -77.8% |
| 2025-03-12 | $0.38 | $0.08 | -78.9% |
| 2024-11-06 | $0.36 | $0.08 | -77.8% |
| $169M |
| — |
| FLUXFlux Power Holdings, Inc. | $0.59 | +1.75% | $13M | — |
| HTLMHomesToLife Ltd | $1.95 | -2.50% | $175M | — |
Source: Financial Modeling Prep · peers by sector/industry